Document Detail


Benign intracranial hypertension: correlation of cerebral blood flow with disease severity.
MedLine Citation:
PMID:  11311474     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Benign intracranial hypertension (BIH) is characterized by symptoms and signs of raised intracranial pressure in the absence of an intracranial mass lesion, infection or hydrocephalus. The purpose of this study was to evaluate the effect of disease severity on cerebral blood flow in patients with BIH on acetazolamide therapy. METHODS: 11 patients (nine females, two males; mean age 30.5 years; range 22-29 years) with BIH were studied. All patients underwent CT and MRI scanning which were normal. The CSF pressure of all patients was above 200 mm H2O. All patients were under treatment with acetazolamide (1 g/day). Disease severity was determined by visual field examination and by clinical symptoms. Five patients were categorized into mild to moderate BIH (group I) and six patients had severe BIH (group II). All patients underwent perfusion brain SPECT with 740 MBq of Tc-99m-HMPAO. RESULTS: Brain perfusion abnormalities were observed in six of the 11 patients. One out of five patients in group I (20%) and five out of six patients (83%) in group II, had abnormal SPECT findings (P<0.04). In four patients of group II the left parietal lobe was involved and another patient had a right occipital abnormality. The single patient from group I with SPECT abnormalities demonstrated focal decreased perfusion in the left temporal area and decreased perfusion in the left caudate nucleus. CONCLUSION: Patients with severe degree of BIH have a higher incidence of cerebral perfusion abnormalities. This group may have an increased risk of cerebrovascular complications. The continuous administration of acetazolamide which affects the vascular autoreactivity may contribute to the regional hypoperfusion. Further studies are recommended to evaluate the natural course of disease versus iatrogenic treatment effects.
Authors:
M Lorberboym; Y Lampl; A Kesler; M Sadeh; N Gadot
Related Documents :
2018244 - Mortality in acute cerebral infarction in young adults--a ten-year experience.
10735984 - Well-being and cerebral oxygen saturation during acute heart failure in humans.
8512504 - Perimesencephalic subarachnoid haemorrhage: negative angiography and favourable prognosis.
7745414 - Outcome in patients with large intraventricular haemorrhages: a volumetric study.
18363754 - A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific ...
22732334 - Prospective multicenter study of hx575 (biosimilar epoetin-α) in patients with chron...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical neurology and neurosurgery     Volume:  103     ISSN:  0303-8467     ISO Abbreviation:  Clin Neurol Neurosurg     Publication Date:  2001 Apr 
Date Detail:
Created Date:  2001-04-20     Completed Date:  2001-09-06     Revised Date:  2009-10-14    
Medline Journal Info:
Nlm Unique ID:  7502039     Medline TA:  Clin Neurol Neurosurg     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  33-6     Citation Subset:  IM    
Affiliation:
Department of Nuclear Medicine, The Edith Wolfson Medical Center, 58100, Holon, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetazolamide / adverse effects,  therapeutic use*
Adult
Brain / blood supply*
Cerebrovascular Circulation
Chronic Disease
Diuretics / adverse effects,  therapeutic use*
Female
Humans
Male
Pseudotumor Cerebri / drug therapy*,  physiopathology,  radionuclide imaging
Radiopharmaceuticals / therapeutic use
Severity of Illness Index
Technetium Tc 99m Exametazime / diagnostic use
Tomography, Emission-Computed, Single-Photon*
Chemical
Reg. No./Substance:
0/Diuretics; 0/Radiopharmaceuticals; 100504-35-6/Technetium Tc 99m Exametazime; 59-66-5/Acetazolamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment-induced neoangiogenesis in cerebral arteriovenous malformations.
Next Document:  Fatal cerebral embolism in a young patient with an occult left atrial myxoma.